 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery |
 |
 |
 |
 |
Phase: |
 |
Phase 1/2 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1839 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
80: Able to perform normal activity with effort; some signs and symptoms of disease |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed Zenapax®-Activated Peptide ImmunoTherapy [ZAP IT] |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
03/02/2008 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Radiation Immunological, Biological or Targeted Therapy |
 |
 |
 |
 |
Contact: |
 |
Henry Friedman MD The Brain Tumor Center at Duke Rm 047 Baker House, Hospital South Trent Drive Durham, NC 27710- USA Phone: (919)684-5301 Fax: (919)684-6674 E-mail: fried003@mc.duke.edu Website: www.cancer.duke.edu/btc |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|